Source: Business Insider
Marcin Golba/NurPhoto via Getty ImagesIn October, Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees. The move comes as GLP-1 drugs consume a growing share of employers' healthcare spending. While some employers retreat from coverage, Bank of America is spending heavily to keep the benefit.
Aller á la Source
Nouvelles connexes